共 104 条
[1]
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
2000, 97 (14)
:8104-8109
Abi-Dargham, A
;
Rodenhiser, J
;
Printz, D
;
Zea-Ponce, Y
;
Gil, R
;
Kegeles, LS
;
Weiss, R
;
Cooper, TB
;
Mann, JJ
;
Van Heertum, RL
;
Gorman, JM
;
Laruelle, M
.
[2]
ADLER LE, 1993, AM J PSYCHIAT, V150, P1856
[3]
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
[J].
BRAIN RESEARCH REVIEWS,
2000, 31 (2-3)
:302-312
Aghajanian, GK
;
Marek, GJ
.
[4]
Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425
[5]
Reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
[J].
BIOLOGICAL PSYCHIATRY,
1998, 44 (02)
:88-97
Benes, FM
;
Kwok, EW
;
Vincent, SL
;
Todtenkopf, MS
.
[6]
BIEDERMAN J, 1979, ARCH GEN PSYCHIAT, V36, P327
[7]
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
[J].
AMERICAN JOURNAL OF PSYCHIATRY,
2002, 159 (06)
:1018-1028
Bilder, RM
;
Goldman, RS
;
Volavka, J
;
Czobor, P
;
Hoptman, M
;
Sheitman, B
;
Lindenmayer, JP
;
Citrome, L
;
McEvoy, J
;
Kunz, M
;
Chakos, M
;
Cooper, TB
;
Horowitz, TL
;
Lieberman, JA
.
[8]
Typical antipsychotic drugs -: D2 receptor occupancy and depressive symptoms in schizophrenia
[J].
SCHIZOPHRENIA RESEARCH,
2002, 56 (1-2)
:31-36
Bressan, RA
;
Costa, DC
;
Jones, HM
;
Ell, PJ
;
Pilowsky, LS
.
[9]
The schizophrenia PORT pharmacological treatment recommendations: Conformance and implications for symptoms and functional outcome
[J].
SCHIZOPHRENIA BULLETIN,
2002, 28 (01)
:63-73
Buchanan, RW
;
Kreyenbuhl, J
;
Zito, JM
;
Lehman, A
.
[10]
Buchanan RW, 1998, AM J PSYCHIAT, V155, P751